Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease

INTRODUCTION: The use of allogeneic hematopoietic cell transplantation (allo-HCT) for treating hematological disorders is increasing, but the development of graft-versus-host disease (GvHD) remains a major cause of morbidity and mortality. The use of post-transplant cyclophosphamide (CY) has signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilman, Kristy E., Cracchiolo, Megan J., Matiatos, Andrew P., Davini, Dan W., Simpson, Richard J., Katsanis, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868157/
https://www.ncbi.nlm.nih.gov/pubmed/36700195
http://dx.doi.org/10.3389/fimmu.2022.1045710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868157/
https://www.ncbi.nlm.nih.gov/pubmed/36700195
http://dx.doi.org/10.3389/fimmu.2022.1045710

Ejemplares similares